首页> 外国专利> METHOD FOR DIFFERENTIAL CORRECTION OF HEMO-COAGULATION DISORDERS IN PATIENTS WITH PURULENT-NECROTIC COMPLICATIONS OF DIABETIC FOOT IN PERIOPERATIVE PERIOD

METHOD FOR DIFFERENTIAL CORRECTION OF HEMO-COAGULATION DISORDERS IN PATIENTS WITH PURULENT-NECROTIC COMPLICATIONS OF DIABETIC FOOT IN PERIOPERATIVE PERIOD

机译:围手术期糖尿病足脓性坏死并发症患者血凝障碍的差异矫正方法

摘要

A method for differential correction of hemo-coagulation disorders in patients with purulent-necrotic complications of diabetic foot in peri-operative period is carried out through medicinal therapy. Preliminarily complex analysis of agregatogram, coagulogram is carried out, and on the determination in patient of hypo-aggregation of thrombocytes and compensation hyper-coagulation of fermentative homeostasis etamsylate sodium, ascorbic acid, nadroparin calcium are prescribed. Infusion therapy includes preparation on basis of gelatin. For patients with hyper-aggregation of thrombocytes and hyper-coagulation of fermentative homeostasis pentosan polysulphate is prescribed, in the case of normocoagulation of fermentative hemostasis clopidogrel, to pre-operation infusion preparation of patients of this sub-group a preparation HEC of 3 generation is prescribed, the patients with relative normoagregation of thrombocytes administer preparations that stabilize vascular wall (sodium etamsylate, ascorbic acid), on reduction of APTT and hyperfibrinogenemia - pentosan polysulphate, on increase of protrombin index - calcium nadroparin.
机译:通过药物治疗,对糖尿病足化脓性坏死并发症患者的围手术期凝血功能障碍进行差异校正。对凝集图,凝血图进行初步的复杂分析,并在确定患者血栓形成过低和确定发酵稳态稳态乙胺磺酸钠,抗坏血酸,萘达帕林钙的补偿性过度凝结方面进行规定。输液治疗包括基于明胶的制备。对于血小板过度聚集和发酵稳态稳态凝固的戊聚糖多硫酸盐的患者,对于发酵止血氯吡格雷的正常凝结,建议对该亚组的患者进行术前输注制备,制备3代HEC处方中,血小板相对正常聚集的患者使用稳定血管壁的制剂(依坦木酸钠,抗坏血酸),降低APTT和高纤维蛋白原血症-戊聚糖多硫酸盐,增加蛋白原指数-萘达帕林钙。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号